Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients.

Tangedal S, Aanerud M, Grønseth R, Drengenes C, Wiker HG, Bakke PS, Eagan TM.

Respir Res. 2017 Aug 29;18(1):164. doi: 10.1186/s12931-017-0645-3.

2.

Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients.

Tangedal S, Aanerud M, Persson LJ, Brokstad KA, Bakke PS, Eagan TM.

Respir Res. 2014 Nov 15;15:138. doi: 10.1186/s12931-014-0138-6.

3.

Analysis of the bacterial community in chronic obstructive pulmonary disease sputum samples by denaturing gradient gel electrophoresis and real-time PCR.

Wu D, Hou C, Li Y, Zhao Z, Liu J, Lu X, Shang X, Xin Y.

BMC Pulm Med. 2014 Nov 18;14:179. doi: 10.1186/1471-2466-14-179.

4.

Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.

Einarsson GG, Comer DM, McIlreavey L, Parkhill J, Ennis M, Tunney MM, Elborn JS.

Thorax. 2016 Sep;71(9):795-803. doi: 10.1136/thoraxjnl-2015-207235. Epub 2016 May 4.

PMID:
27146202
5.

Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.

Diao W, Shen N, Du Y, Erb-Downward JR, Sun X, Guo C, Ke Q, Huffnagle GB, Gyetko MR, He B.

Int J Chron Obstruct Pulmon Dis. 2018 Jul 30;13:2289-2299. doi: 10.2147/COPD.S167618. eCollection 2018.

6.

The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.

Huang YJ, Boushey HA.

Ann Am Thorac Soc. 2015 Nov;12 Suppl 2:S176-80. doi: 10.1513/AnnalsATS.201506-319AW.

7.

Short term dynamics of the sputum microbiome among COPD patients.

Sinha R, Weissenburger-Moser LA, Clarke JL, Smith LM, Heires AJ, Romberger DJ, LeVan TD.

PLoS One. 2018 Mar 8;13(3):e0191499. doi: 10.1371/journal.pone.0191499. eCollection 2018.

8.

Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.

Hahn A, Sanyal A, Perez GF, Colberg-Poley AM, Campos J, Rose MC, Pérez-Losada M.

J Microbiol Methods. 2016 Nov;130:95-99. doi: 10.1016/j.mimet.2016.09.002. Epub 2016 Sep 5.

9.

Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients.

Tangedal S, Nielsen R, Aanerud M, Persson LJ, Wiker HG, Bakke PS, Hiemstra PS, Eagan TM.

PLoS One. 2019 Sep 17;14(9):e0222449. doi: 10.1371/journal.pone.0222449. eCollection 2019.

10.

Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.

Pragman AA, Knutson KA, Gould TJ, Isaacson RE, Reilly CS, Wendt CH.

Respir Res. 2019 Jun 7;20(1):114. doi: 10.1186/s12931-019-1080-4.

11.

Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.

Wang Z, Singh R, Miller BE, Tal-Singer R, Van Horn S, Tomsho L, Mackay A, Allinson JP, Webb AJ, Brookes AJ, George LM, Barker B, Kolsum U, Donnelly LE, Belchamber K, Barnes PJ, Singh D, Brightling CE, Donaldson GC, Wedzicha JA, Brown JR; COPDMAP.

Thorax. 2018 Apr;73(4):331-338. doi: 10.1136/thoraxjnl-2017-210741. Epub 2017 Dec 21.

12.

Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.

Molyneaux PL, Mallia P, Cox MJ, Footitt J, Willis-Owen SA, Homola D, Trujillo-Torralbo MB, Elkin S, Kon OM, Cookson WO, Moffatt MF, Johnston SL.

Am J Respir Crit Care Med. 2013 Nov 15;188(10):1224-31. doi: 10.1164/rccm.201302-0341OC.

13.

Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han Males.

Lee SW, Kuan CS, Wu LS, Weng JT.

PLoS One. 2016 Jul 18;11(7):e0159066. doi: 10.1371/journal.pone.0159066. eCollection 2016.

14.

[Comparison Study of Oropharyngeal Microbiota in Case of Bronchial Asthma and Chronic Obstructive Pulmonary Disease in Different Severity Levels].

Ogorodova LM, Fedosenko SV, Popenko AS, Petrov VA, Tyakht AV, Saltykova IV, Deev IA, Kulikov ES, Kirillova NA, Govorun VM, Kostryukova ES.

Vestn Ross Akad Med Nauk. 2015;(6):669-78. Russian.

PMID:
27093794
15.

Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease.

Dicker AJ, Crichton ML, Pumphrey EG, Cassidy AJ, Suarez-Cuartin G, Sibila O, Furrie E, Fong CJ, Ibrahim W, Brady G, Einarsson GG, Elborn JS, Schembri S, Marshall SE, Palmer CNA, Chalmers JD.

J Allergy Clin Immunol. 2018 Jan;141(1):117-127. doi: 10.1016/j.jaci.2017.04.022. Epub 2017 May 13.

16.

Exacerbation induces a microbiota shift in sputa of COPD patients.

Jubinville E, Veillette M, Milot J, Maltais F, Comeau AM, Levesque RC, Duchaine C.

PLoS One. 2018 Mar 26;13(3):e0194355. doi: 10.1371/journal.pone.0194355. eCollection 2018.

17.

Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.

Garcia-Nuñez M, Millares L, Pomares X, Ferrari R, Pérez-Brocal V, Gallego M, Espasa M, Moya A, Monsó E.

J Clin Microbiol. 2014 Dec;52(12):4217-23. doi: 10.1128/JCM.01967-14. Epub 2014 Sep 24.

18.

Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease.

Cabrera-Rubio R, Garcia-Núñez M, Setó L, Antó JM, Moya A, Monsó E, Mira A.

J Clin Microbiol. 2012 Nov;50(11):3562-8. doi: 10.1128/JCM.00767-12. Epub 2012 Aug 22.

19.

Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.

Huang YJ, Sethi S, Murphy T, Nariya S, Boushey HA, Lynch SV.

J Clin Microbiol. 2014 Aug;52(8):2813-23. doi: 10.1128/JCM.00035-14. Epub 2014 May 21.

20.

Optimisation of methods for bacterial skin microbiome investigation: primer selection and comparison of the 454 versus MiSeq platform.

Castelino M, Eyre S, Moat J, Fox G, Martin P, Ho P, Upton M, Barton A.

BMC Microbiol. 2017 Jan 21;17(1):23. doi: 10.1186/s12866-017-0927-4.

Supplemental Content

Support Center